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The antibacterial activity of hygromycin A (HA) arises
from protein synthesis inhibition and is dependent
uponamethylenedioxybridged-aminocyclitolmoiety.
Selective gene deletions and chemical complementa-
tion in Streptomyces hygroscopicus NRRL 2388
showed that the hyg18 and hyg25 gene products,
proposed to generate a myo-inositol intermediate,
are dispensable for HA biosynthesis but contribute
to antibiotic yields. Hyg8 and Hyg17, proposed to
introduce the amine functionality, are essential for
HA biosynthesis. Hyg6 is a methyltransferase acting
on the aminocyclitol, and a Dhyg6 mutant produces
desmethylenehygromycin A. Deletion of hyg7, a met-
allo-dependant hydrolase homolog gene, resulted in
methoxyhygromycin A production, demonstrating
that the corresponding gene product is responsible
for the proposed oxidative cyclization step of methyl-
enedioxy bridge formation. The methyl/methylene
group is not required for in vitro protein synthesis
inhibition but is essential for activity against Escheri-
chia coli.
INTRODUCTION
Aminocyclitols, which are characterized by the presence of
a cyclohexane moiety with hydroxyl and amino or guanidino
substituents, are found in a large class of natural products with
broad-ranging biological properties. The aminocyclitol-amino-
glycosides have long been known for their antibacterial activities
and have found applications as antibiotics in clinical use (strepto-
mycin, gentamicin, and kanamycin), veterinary medicine (specti-
nomycin), and agriculture (kasugamycin and validamycin A) (Flatt
and Mahmud, 2007; Mahmud, 2009). The C7N aminocyclitol-
containing compound, acarbose, has a-glucosidase inhibitory
activity, potentially useful in the treatment of type II insulin-inde-
pendent diabetes mellitus (Mahmud, 2003). Structure-activity
relationship studies have established the importance of the
aminocyclitol moiety for the biological activity of many of these
natural products. Genetic and biochemical studies have also
revealed the complexity and diversity of the biosynthetic path-1180 Chemistry & Biology 16, 1180–1189, November 25, 2009 ª200ways that produce these critical aminocyclitol moieties (Flatt
and Mahmud, 2007; Mahmud, 2009).
Hygromycin A (HA, compound 1) (Figure 1) is a secondary
metabolite produced by the soil bacterium Streptomyces hygro-
scopicus NRRL 2388 (Mann et al., 1953; Pittenger et al., 1953).
HA is structurally distinguished by the presence of three distinct
moieties, 5-dehydro-a-L-fucofuranose (subunit A), (E)-3-(3,4-
dihydroxyphenyl)-2-methylacrylic acid (subunit B), and the ami-
nocyclitol, 2L-2-amino-2-deoxy-4,5-O-methylene-neo-inositol
(subunit C). The mechanism of action of HA as a bacterial
ribosomal peptidyl transferase inhibitor, and also its hemaggluti-
nation inactivation, antitreponemal, and immunosuppressant
properties have been well-elucidated (Guerrero and Modolell,
1980; Nakagawa et al., 1987; Omura et al., 1987; Uyeda et al.,
2001; Yoshida et al., 1986). Herbicidal properties have been
identified for HA and methoxyhygromycin A (2) (Figure 1), a shunt
product or pathway intermediate obtained in the course of HA
biosynthesis (Kim et al., 1990; Lee et al., 2003). Structure-activity
relationship studies have revealed that subunit C is indispens-
able for HA’s antibacterial activity (Hayashi et al., 1997).
A plausible pathway for HA biosynthesis has been proposed,
based on isotope-labeled precursor incorporation studies
(Habib et al., 2003). Analyses of labeling patterns of the resulting
HA have shown that (1) subunit A originates from glucose-6-
phosphate via a mannose intermediate, (2) the central subunit
B is derived from 4-hydroxybenzoic acid and propionic acid in
a polyketide-like manner, and (3) myo-inositol and methionine
are the precursors for subunit C. It has further been suggested
that the glycoside bond (which links subunits A and B) and the
amide bond (linking subunits B and C) are formed after each of
the subunits is assembled. The results from the biosynthetic
incorporation studies provided a strategy for identification, and
subsequent cloning and sequencing of the HA biosynthetic
gene cluster of S. hygroscopicus (GenBank DQ314862) (Pala-
niappan et al., 2006). Analysis of this 31.5 kb gene cluster led
to the identification of 29 open reading frames (ORFs).
Several of the gene products were assigned putative roles
in biosynthesis of the aminocyclitol subunit of HA. In the
proposed pathway, glucose-6-phosphate is first converted to
myo-inositol-1-phosphate (MIP) by a myo-inositol-1-phosphate
synthase encoded by hyg18. MIP is then dephosphorylated
to form myo-inositol by the hyg25 gene product, a putative
myo-inositol phosphatase. Analogous steps are also encoun-
tered in the biosynthesis of the aminocyclitol moiety of9 Elsevier Ltd All rights reserved
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Biosynthesis of Aminocyclitol Subunit Hygromycin AFigure 1. Relationship between Hygromycin A Analogs and the Biosynthetic Pathway Leading to the Aminocyclitol Moiety
The three structural moieties, 5-dehydro-a-L-fucofuranose (subunit A), (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic acid (subunit B), and 2L-2-amino-2-deoxy-
4,5-O-methylene-neo-inositol (subunit C) are indicated.streptomycin, bluensomycin, spectinomycin, fortimicin, and the
D-inositol of kasugamycin (Flatt and Mahmud, 2007). The subse-
quent oxidation and transamination reactions in the above
compounds occur at the C2 hydroxyl of myo-inositol to form
scyllo-inosamine, whereas in the case of HA biosynthesis the
labeling studies are consistent with them occurring at the C5
hydroxyl, leading to the unique neo-inosamine-2 product. An
inositol dehydrogenase (encoded by hyg17) and a putative
aminotransferase (encoded by hyg8) were proposed to catalyze
these steps, respectively. A distinct structural feature of HA is the
methylenedioxy bridge between C4 and C5 of the C subunit,
shown to be derived from S-adenosylmethionine (SAM). It has
been proposed that the bridge formation involves methylation
of the C5 hydroxyl group of neo-inosamine-2 (which is equivalent
to C1 of myo-inositol) by a SAM-dependent methyltransferase,
followed by cyclization. The hyg6 and hyg29 genes in the HA
gene cluster are methyltransferase homologs, and it was not
possible to determine from sequence analysis which of the two
encodes the putative O-methyltransferase acting on neo-inos-
amine-2. No candidate gene for the subsequent cyclization
step was identified and sequence analysis gave no insight into
the timing of the various steps.Chemistry & Biology 16, 1180–11We report herein a verification of the proposed roles of these
hyg genes in biosynthesis of the aminocyclitol subunit through
a series of targeted gene disruption experiments and chemical
complementation studies. A biologically active new desmethy-
lene analog of HA has been purified and characterized from
a Dhyg6 mutant, demonstrating that Hyg6 is the C5 O-methyl-
transferase that introduces the methyl group on the aminocycli-
tol and that introduction of the amine group can occur without
this step. The analyses have also shown that the hyg7 gene
product is required for the cyclization step that generates the
methylenedioxy bridge. The selective production of hygromycin
analogs by the Dhyg6 and Dhyg7 mutants has provided an
opportunity to probe the importance of a methyl or methylene
group on the aminocylitol ring for both in vitro protein synthesis
inhibitory activity and antibacterial activity.
RESULTS
Hygromycin Production by Mutant Strains
The HA biosynthetic gene cluster harbors seven genes that
are predicted to be functional in the biosynthesis of the 2L-2-
amino-2-deoxy-4,5-O-methylene-neo-inositol moiety (subunit C)89, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1181
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Biosynthesis of Aminocyclitol Subunit Hygromycin ATable 1. Results of Feeding Antibiotic Precursors to Different hyg Mutant Strains
Strain
Antibiotic Production
Production with myo-inositol
Supplementation
Production with
Subunit C Supplementation
HA (mg/l) 3 (mg/l) 5 (mg/l) HA (mg/l) 3 (mg/l) 5 (mg/l) HA (mg/l) 3 (mg/l) 5 (mg/l)
Wild type 1190 ± 120 1090 ± 40
Dhyg18 (myo-inositol-1-
phosphate synthase)
588 ± 21 1090 ± 15
Dhyg25 (myo-inositol-1-
phosphatase)
961 ± 84 956 ± 74
Dhyg17 (myo-inositol
dehydrogenase)
147 ± 20 204 ± 41 630 ± 12
Dhyg8 (Aminotransferase) — — N/D
Dhyg8+Dhyg7 3 ± 1
Dhyg6 (Methyltransferase) — — 530 ± 60 435 ± 30 180 ± 90 690 ± 270
Dhyg29 (Methyltransferase) 485 ± 21
Dhyg7 287 ± 19 411 ± 19 671 ± 40 386 ± 33
N/D, not detectable.(Palaniappan et al., 2006). A polymerase chain reaction (PCR)-
targeted gene replacement strategy for in vivo functional
analyses of these genes was used (Gust et al., 2003) and the
fermentation broths of the corresponding mutants were exam-
ined for the presence of HA or its analogs. The mutants were
also chemically complemented with either subunit C (the putative
final product of the aminocyclitol pathway) or the putative myo-
inositol intermediate, and the effect on product ratios and yields
were determined (Table 1).
The involvement of myo-inositol-1-phosphate synthase and
myo-inositol phosphatase to generate myo-inositol from glu-
cose-6-phosphate has been reported from a host of diverse
sources such as higher plants and animals, parasites, fungi,
green algae, bacteria, and archaea (Majumder et al., 2003).
The hyg18 gene product is proposed to be a myo-inositol-1-
phosphate synthase and the Dhyg18 mutant produced HA, 3,
and their corresponding C500-reduced analogs 2 and 4 (Figure 1)
at approximately 50% of the levels observed for the wild-type
strain (Table 1). A small amount (23 mg/l) of (E)-3-(3-hydroxy-
4-O-a-fucofuranosylphenyl)-2-methylacrylic acid (7) (Figure 1)
was also observed. This shunt product is not observed in the
wild-type but has been identified previously in the SCH30
(short-chain dehydrogenase,Dhyg26) mutant (Palaniappan et al.,
2006). Chemical complementation of the Dhyg18 mutant with
myo-inositol led to almost complete restoration of HA and loss
of production of the 7 shunt product. In contrast, no increase in
HA yields was observed with addition of myo-inositol to the
wild-type strain (suggesting that myo-inositol is limiting in the
Dhyg18mutant but not in the wild-type). The hyg25 gene product
is predicted to be a myo-inositol phosphatase, and a Dhyg25
mutant was observed to produce HA in amounts comparable
to that in the wild-type, both in the absence and presence of
myo-inositol.
Blocking the aminocyclitol pathway at steps subsequent to
the proposed myo-inositol intermediate had more pronounced
effects on antibiotic production. Disruption of hyg17, which
presumably encodes a myo-inositol dehydrogenase for C5
oxidation of myo-inositol, resulted in an 8-fold decrease in
HA production (Table 1). Consistent with predictions, chemical1182 Chemistry & Biology 16, 1180–1189, November 25, 2009 ª200complementation of the Dhyg17 mutant with myo-inositol did
not lead to restoration of HA production. Chemical complemen-
tation of this mutant with subunit C led to a 4-fold increase in
HA production levels, to approximately 50% of that seen in
the wild-type. This experiment provided clear evidence that
Hyg17 operates at a step in the aminocyclitol pathway after
formation of the myo-inositol and that the final subunit C can
be incorporated intact into HA. The Dhyg17 strain was also
grown in the presence of valienamine, the C7N aminocyclitol
moiety used in biosynthesis of the antifungal antibiotic validamy-
cin A (Mahmud et al., 2007). Liquid chromatography mass spec-
trometry (LC-MS) analyses of the fermentation broth showed
the presence of an ionic species with a [M+H]+ of 496 amu, the
expected mass resulting from valienamine incorporation in
place of the normal biosynthetic aminocyclitol moiety. A limited
supply of valienamine precluded efforts to purify the proposed
new HA analog for either structural elucidation or bioactivity
assays. Further mutasynthesis experiments in Dhyg17 using
amino sugars such as glucosamine, galactosamine, and man-
nosamine did not result in production of any detectable new
HA products.
The hyg8 gene is proposed to encode a putative class III
pyridoxal-phosphate-dependent aminotransferase, catalyzing
transamination of C5-oxidized myo-inositol to produce neo-
inosamine-2 (Palaniappan et al., 2006). A complete loss of HA
production was observed in the Dhyg8 mutant and could not
be restored by chemical complementation with subunit C. An
additional mutation, where hyg7 and hyg8 were both deleted,
also abolished HA production completely. In this case, however,
very low levels of HA production were observed with subunit C
addition. As described below, aDhyg7mutant gives dramatically
different results, and the loss of HA production and poor chem-
ical complementation with subunit C appear to be linked to loss
of hyg8.
The hyg6 and hyg29 genes show homology to methyltrans-
ferases and analysis of their predicted amino acid sequences
did not indicate which of them was likely required for the
proposed SAM-dependant methylation of neo-inosamine-2.
A Dhyg29 mutant was generated, and high-performance liquid9 Elsevier Ltd All rights reserved
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broth of this strain revealed the same products (HA and 3) at
approximately 60% of those seen in the wild-type. In contrast,
the production of HA was completely abolished in aDhyg6 strain,
and HPLC analysis of the fermentation broth of this mutant
revealed a dominant new peak and an additional minor peak
with shorter retention times than HA under the standard
reverse-phase HPLC conditions (Figure 2). The major peak
showed a mass in negative mode of m/z = 498 [M - H]- and the
minor peak showed a mass of m/z = 500 [M - H]-. An m/z of
499 is consistent with the mass of HA that is missing the methy-
lene group bridging O-4 and O-5. An m/z of 501 observed for the
smaller peak corresponds to a reduced derivative of the major
peak. The MS analyses were thus consistent with production
of desmethylene HA analogs (5, 6) (Figure 1) by the Dhyg6 strain.
The production titers of 5 were 400 mg/l. When subunit C was
provided to this strain, low levels of HA could be observed
although the levels of 5 were not significantly altered.
A unique feature of the aminocyclitol moiety of HA is the C4-C5
methylenedioxy bridge, which is essential for optimal biological
activity (Hecker et al., 1992). Sequence analyses of the 29
ORFs of the HA gene cluster did not reveal a putative candidate
gene product for the cyclization step of bridge formation. We had
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Figure 2. Effect of Methyltransferase gene
(hyg6, hyg29) Disruptions on Hygromycin A
Production
(A) Reverse-phase HPLC analysis of fermentation
broths of wild-type, Dhyg29, and Dhyg6 strains.
Disruption of hyg29 caused a decrease in hygro-
mycin A production. Disruption of hyg6 resulted
in the generation of new metabolites with shorter
retention times than hygromycin A.
(B) Mass spectrometric analysis (negative mode)
of Dhyg6 fermentation broth. Two new species
were identified with [M-H]- values of 498 and 500
corresponding to desmethylenehygromycin A (5)
and 500-dihydrodesmethylenehygromycin A (6),
respectively.
hypothesized that the hyg7 gene product,
which is homologous to D-aminoacy-
lases/amidohydrolases, mediates forma-
tion of the amide bond between subunits
B and C, and that a Dhyg7 mutant would
accumulate 7. However, as shown in
Figure 3A, the Dhyg7 strain produced 3
and trace levels of 4. Chemical comple-
mentation with subunit C, but not myo-
inositol, led to a restoration of HA produc-
tion (55% of that seen in the wild-type
strain) (Figure 3A). A series of chemical
complementation experiments of this
strain with subunit C in the presence of
either radiolabeled [2-3H] myo-inositol or
[carboxyl-14C] 4-hydroxybenzoic acid
was also carried out (Figure 3B). These
analyses demonstrated that while HA
production was restored by supplemen-
tation with subunit C, radiolabeled myo-
inositol incorporation was only observed into 3. A similar study
with radiolabeled 4-hydroxybenzoic acid resulted, predictably,
in its incorporation into both HA and 3. Taken together, these
observations clearly indicate that cyclization of the C5 methoxy
group, resulting in formation of the methylenedioxy bridge, is
dependant upon the hyg7 gene product.
Structural Elucidation of Desmethylene HA Analogs
The two new compounds isolated from the Dhyg6 strain were
purified by semipreparative HPLC and their structures were
elucidated by nuclear magnetic resonance (NMR). The most
obvious change observed in the 1H-NMR spectra of 5 and 6
was the absence of either the three-proton singlet at 3.5 ppm
(for the O-5 methyl group of 3), or two one-proton singlets
at 5.18 ppm and 4.83 ppm (for the methylene group bridging
O-4 and O-5 of HA).
The differences in the 1H-NMR spectra between 5 and 6
involve the fucofuranose moiety. The H-600 signal for 5 is a singlet
at 1.99 ppm (overlapping with protons from a–CH3), whereas the
H-600 signal for 6 is a doublet at 1.20 ppm. The H-400 signal is also
shifted from 4.4 ppm in 5 to 3.74 ppm in 6 (shifts are approxi-
mate for H-400 in 5 because this signal is obscured by other
signals at the same chemical shift). There is also a new signalChemistry & Biology 16, 1180–1189, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1183
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Figure 3. Effect of hyg7 Gene Disruption on
Hygromycin A Production
(A) Reverse-phase HPLC analysis of Dhyg7
fermentation broth. The Dhyg7 strain produced
only compound 3. Restoration of HA production
was observed upon subunit C supplementation
as seen in the HPLC chromatogram ‘‘Dhyg7-C.’’
(B) HPLC analysis of Dhyg7 fermentation supple-
mented with C subunit in the presence of [2-3H]
myo-inositol or [carboxyl-14C] 4-hydroxybenzoic
acid. Dhyg7-C-MI(UV) and Dhyg7-C-pHBA(UV) are
UV traces of fermentation broth of Dhyg7 supple-
mented with subunit C in the presence of [2-3H]
myo-inositol and [carboxyl-14C] 4-hydroxybenzoic
acid, respectively. Dhyg7-C-MI(R) and Dhyg7-
C-pHBA(R) represent the radiolabeled traces
recorded by Beta-Ram (R) radioactivity quantiza-
tion system for their respective UV traces. This
analysis clearly indicated the role of hyg7 in the
cyclization step of methylenedioxy bridge forma-
tion.for H-500 of 6 that appears at approximately 3.79 ppm, which is
obscured by other signals.
Activity of Desmethylenehygromycin A
The antibacterial activity of 5 was determined using DtolC E. coli
as test organism and compared with that of HA, 3, and 7 to
determine the importance of the methyl/methylene group on
the cyclitol. The MIC90 of HA for DtolC E. coli was determined
to be 10 mg/ml (Table 2). Compounds 3 and 5 had much less
activity, with the MIC90 for both being 150 mg/ml. Compound 7
lacked inhibitory activity even at a concentration of 250 mg/ml.
The compounds were also assessed for their ability to inhibit
the synthesis of green fluorescent protein (GFP) using an
E. coli in vitro coupled transcription-translation system (Dinos
et al., 2004; Szaflarski et al., 2008). HA was shown to be highly
active in vitro, having an IC50 and IC90 of 0.18 mM and 0.25 mM,
respectively, whereas compound 7 was inactive exhibiting no
effect on translation at 75 mM. In contrast to their poor MIC
values, both 3 and 5 displayed significant activity as in vitro tran-
scription-translation inhibitors, although their IC50/90 values were
higher than those of HA (Table 2, Figure 4).
Resistance of Dhyg29Mutant Strain to HA
In order to verify whether the hyg29 gene contributed to self-
resistance of S. hygroscopicus, spores of the wild-type and
Dhyg29 strains were grown on agar plates with different HA
concentrations. The MIC95 of HA for the wild-type was found
to be 400 mg/ml. The mutant also showed high level of self-resis-
tance, with an MIC95 value of 300 mg/ml.
Table 2. Comparison of MIC90 and IC50/90 Data for Hygromycin A
and Analogs
HA 3 5 7
MIC90 (mg/ml) 10 150 150 >250
IC50 (mM) 0.18 0.5 0.32 >75
IC90 (mM) 0.25 2 1 >751184 Chemistry & Biology 16, 1180–1189, November 25, 2009 ª200DISCUSSION
Myo-inositol represents a common intermediate in the majority
of pathways that generate aminocyclitol components of amino-
glycoside antibiotics (Flatt and Mahmud, 2007; Mahmud,
2009). Branch points from this intermediate then give rise to
the various products. In the proposed biosynthetic pathway
(Figure 1B) that generates the aminocyclitol moiety of hygromy-
cin A, this branching step is oxidation of the C5 hydroxyl of myo-
inositol to form neo-inosose (Habib et al., 2003). The steps that
precede myo-inositol are well known, reasonably widespread
in organisms, and involve the sequential action of a MIP synthase
(catalyzing formation of myo-inositol- phosphate from glucose
6-phosphate) and a MIP phosphatase. In actinomycetes these
are essential activities, required for the biosynthesis of the
essential metabolite mycothiol (the major cellular thiol and redox
co-catalyst). For this reason, actinobacterial genomes mostly
harbor more than one gene, and sometimes have several genes
with either L-myo-inositol-1-phosphate synthase or inositol
monophosphatase signatures (Wehmeier and Piepersberg,
2009). Thus for many aminocyclitol pathways, it appears that
genes encoding these two enzymes are not necessarily located
within the corresponding biosynthetic gene cluster. In the strep-
tomycin producer S. griseus, a MIP synthase has been purified
and it has been shown that the corresponding gene is not
present in the streptomycin biosynthetic gene cluster (Flatt and
Mahmud, 2007; Pittner et al., 1979; Sipos and Szabo, 1989).
The MIP synthase is also lacking in the biosynthetic gene clus-
ters of bluensomycin and spectinomycin (Flatt and Mahmud,
2007), although this enzymatic activity is presumably required
for formation of these natural products. The partial loss of HA
production with deletion of hyg18 and restoration with myo-
inositol are consistent with (1) Hyg18 encoding a putative MIP
synthase required for efficient production of MIP and (2) the
presence of an additional MIP synthase that can catalyze this
reaction in Streptomyces hygroscopicus. A MIP phosphatase
gene is present in the streptomycin (strO) and spectinomycin9 Elsevier Ltd All rights reserved
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chemically confirmed (Ahlert et al., 1997; You-Young et al.,
2003), although it has not been determined if these genes are
essential for biosynthesis of the antibiotics. The hyg25 gene
product has conserved domains of the haloacid dehalogenase
like hydrolase superfamily, which includes phosphatases
(although there is no significant sequence similarity between
Hyg25, and either known MIP phosphatases, StrO or SpeA).
The wild-type production levels of HA by the hyg25 mutant do
not provide evidence that Hyg25 is a MIP phosphatase.
However, because this is the only putative phosphatase in the
HA biosynthetic gene cluster, the evidence indicates that an
enzyme not encoded by the hyg gene cluster can catalyze
dephosphorylation of MIP.
Figure 4. Effect of Hygromycin A and Derivatives on In Vitro Tran-
scription-Translation
(A) Detection of template-dependent synthesis of GFP using fluorescence in
the absence or presence of increasing concentrations (mM) of the antibiotic
hygromycin A (HA), methoxyhygromycin A (3), desmethylenehygromycin A
(5), or 500-dihydroAB subunit (7) (see Figure 1 for structures).
(B) Quantitation of (A). GFP fluorescence is given as a percentage where 100%
is defined as the fluorescence detected in the absence of the antibiotic.Chemistry & Biology 16, 1180–11Steps subsequent to myo-inositol intermediate involve
introduction of the amine functionality (at the C-5 hydroxyl) and
introduction of the methyl group (at the C2 hydroxyl group).
Although the exact order of these steps in the normal biosyn-
thetic process is unclear, the production of desmethylenehygro-
mycin A by Dhyg6 demonstrates that the amine functionality
can be introduced without the methyl group. In such a pathway,
the C-5 hydroxyl group would be oxidized to form neo-inosose,
with a subsequent transamination to form neo-inosamine-2
(Figure 1B). The data withDhyg17 strain (an almost a 90% reduc-
tion in HA yields relative to wild-type strain, and a 4-fold increase
in these yields with supplementation with subunit C, but notmyo-
inositol) support the proposed role of this gene product as an
myo-inositol dehydrogenase. The continued production of low
levels of HA in this strain suggests that another enzyme or
enzymes present in S. hygroscopicus are able to catalyze C5
oxidation of myo-inositol. The data with the Dhyg8 mutant
(complete loss of HA production and modest HA production on
supplementation with the subunit) support the proposed role of
the gene product as the pyridoxal-phosphate-dependent amino-
transferase that introduces the amine functionality. The poor
yields of HA in the chemical complementation experiments
with subunit C are puzzling, given how effective this moiety is
at restoring HA production in other mutants. The HA shunt
product 7, which would be expected to form in the absence of
adequate levels of the aminocyclitol moiety, was not observed
in Dhyg8. A polar effect from replacement of hyg8 with the
apramycin resistance marker may account for these observa-
tions (the current lack of a genetic complementation system
did not permit this possibility to be tested). Another possible
explanation is that the intermediate neo-inosamine-2 may
have a key regulatory role. In principle, only Dhyg8 is unable to
generate this intermediate.
The production of desmethylene analogs 5 and 6 by theDhyg6
strain provide conclusive evidence that the C4-C5 methylene
group in HA (and the methyl group in 3) is carried out by an
O-methylation activity of Hyg6 and not by Hyg29, the second
methyltransferase homolog in the HA gene cluster (Figure 1).
The high titers of 5 and 6 also demonstrate that introduction of
the amine functionality in myo-inositol is not dependant upon
methylation. The MIC analyses showed that the antibacterial
activity of 5 against DtolC E. coli was 15 times less than that of
HA. Interestingly, the MIC value of 5 was the same as that of 3,
which has a C5-OCH3 group instead of the methylenedioxy
bridge. The lower antibacterial activity of 3 has been reported
previously (Chida et al., 1990; Yoshida et al., 1986). HA analogs
in which the aminocyclitol is replaced by aminocyclohexadiols
and aminocyclohexatriols have also shown markedly reduced
biological activity (Hecker et al., 1992). The MIC data on the
new shunt product 5 finalize these analyses, demonstrating
that for maximal antibiotic activity subunit C must be an amino-
cyclitol and that this must be modified through formation of the
methylenedioxy bridge. An unexpected observation is that
removal of the methylenedioxy ring does not lead to a loss in
the in vitro protein synthesis inhibition activity. Compounds 3
and 5, where the methylenedioxy ring is disrupted, both retained
potent protein synthesis inhibitory activity despite showing poor
MIC values (Figure 4, Table 2). In contrast compound 7, which
lacks the aminocyclitol ring, is totally inactive. In fact, the IC5089, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1185
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macrolide antibiotic tylosin (0.4 mM) in the same in vitro tran-
scription-translation assay (A.L.S. and D.N.W., unpublished
data). These data suggest that the aminocyclitol ring is indeed
essential for translation inhibition activity, whereas an intact
methylenedioxy ring is not. It appears that the loss in biological
activity due to methylenedioxy ring disruption stems from
another factor, potentially a reduced uptake of the drug into
the cell rather than abolishing the ribosome binding ability of
the compound.
Inactivation of the second methyltransferase homolog, hyg29,
resulted in a decrease in the yield of HA, although the antibiotic
production profile and self-resistance were not affected.
Because HA binds to the ribosomes, rRNA methylation by
Hyg29 may provide a self-resistance mechanism in S. hygrosco-
picus. There is as yet no evidence to support such a role for
hyg29 and, moreover, ribosomal self-resistance is not always
observed for ribosome-targeting antibiotics (e.g., oleandomycin)
(Cundliffe, 1989). If the hyg29 gene product is indeed an rRNA
methylase, the high level of HA resistance of the Dhyg29 mutant
suggests that in the absence of target-site modification by
hyg29, self-resistance is possibly being conferred by the other
resistance determinants in the HA gene cluster, namely a HA
inactivating O-phosphotransferase (Dhote et al., 2008), and
putative efflux pumps encoded by hyg19 and hyg28.
The final step in the proposed pathway for formation of the
C-subunit of HA is an oxidative cyclization to provide the meth-
ylenedioxy bridge. No gene product likely responsible for cata-
lyzing this step was identified in the initial analyses of the hyg
biosynthetic gene cluster (Palaniappan et al., 2006). The role of
the hyg7 gene product was unknown. A more detailed analysis
has revealed clear homology of Hyg7 with aminoacylases, which
catalyze hydrolytic deacetylation of N-acetyl-D-amino acids.
Furthermore, Hyg7 is a member of the metallo-dependant hydro-
lase superfamily. Enzymes in this class have hydrolytic activities
and typically have two, or less commonly one, metal ion-binding
sites (Lai et al., 2004). Our analysis of Hyg7 revealed the four
highly conserved residues (a Cys, Asp, and two His) that
comprise a single metal-binding site and suggest a role in
a hydrolytic process. Nonetheless, the selective production of
methoxyhygromycin A (3) by Dhyg7 and the restoration of HA
upon supplementation with subunit C clearly demonstrate
that Hyg7 is required for the oxidative cyclization process which
forms the methylenedioxy bridge of HA. Natural products with
a methylenedioxy bridge have been identified more commonly
in plants, and involve an initial methylation with subsequent
action by a cytochrome p450 enzyme complex (Ikezawa et al.,
2003). There are a limited number of examples of secondary
metabolites from actinomycetes possessing methylenedioxy
bridge. A 1,3-dioxine ring is found in dioxapyrrolomycin
from Streptomyces fumanus, simaomicin from Actinomadura
madurae, and the streptovaricins from Streptomyces spectabilis
(Charan et al., 2006; Carter et al., 1989; Staley and Rinehart,
1991). FR-900109 from S. prunicolor, the dioxolides from
S. tendae, and pseudoverticin from S. pseudoverticillus possess
a 1,3-dioxolane ring similar to that seen in HA (Blum et al., 1996;
Cui et al., 2007; Koda et al., 1983). Deuterium labeling studies in
dioxapyrrolomycin by Charan et al. indicated an oxidative cycli-
zation mechanism for methylenedioxy bridge formation similar to1186 Chemistry & Biology 16, 1180–1189, November 25, 2009 ª200that reported for the plant metabolite berberine (Bjorklund et al.,
1995; Charan et al., 2006). The pyr20 gene product in the biosyn-
thetic gene cluster of pyrrolomycin has resemblance to cyto-
chrome P450 enzymes (and not to Hyg7) and has been proposed
to potentially carry out the above function (Zhang and Parry,
2007). However, to the best of our knowledge there have been
no genetic or biochemical characterization of the processes
that lead to methylenedioxy bridge formation in bacterial natural
product biosynthesis. Our results with hyg7 represent the first
example of in vivo characterization of a functional methylene-
dioxy bridge-forming gene of bacterial origin. Furthermore, the
data indicate that a member of the metallo-dependent hydrolase
superfamily, rather than a cytochrome p450 enzyme, is involved.
The role of Hyg7 in this process, and the need for other enzymes
or cofactors, remains to be biochemically determined.
The ability of subunit C to restore HA biosynthesis in most of
the mutants described herein, demonstrates that it is an effective
substrate for the enzyme that catalyzes amide bond formation. It
is thus possible that the normal HA biosynthetic process involves
formation of a complete C subunit prior to formation of the amide
bond. Formation of 3 and 5, and the apparent incorporation of
valienamine, suggest relaxed substrate specificity of the corre-
sponding coupling enzyme (Figure 1B). However, the data do
not preclude the possibility that the final steps of C-subunit
biosynthesis (methylation and formation of the methylenedioxy
bridge) occur after amide bond formation.
SIGNIFICANCE
The roles of key hyg gene products in formation of the struc-
turally unusual, methylene-bridged aminocyclitol of HA
have been elucidated. Deletion of key genes in the pathway
leads in some cases to accumulation of intermediates in
the aminocyclitol biosynthetic process. As such the genetic
tools to access novel HAs in Streptomyces hygroscopicus
and to generate various aminocyclitols for combinatorial
biosynthetic processes (generating new structurally diverse
compounds) have been identified. The methylenedioxy
bridge in HA has been shown not to be required for in vivo
versus translation inhibition activity, but is required for bio-
logical uptake. These discoveries may help in the continued
evaluation of HA-based structures for development of novel
antibacterials. The discovery of the need for Hyg7 in the
oxidative cyclization that yields the methylene-bridged ami-
nocyclitol suggests a newenzymatic paradigm for formation
of these unusual structural moieties.
EXPERIMENTAL PROCEDURES
Chemicals, Bacterial Strains, Growth Conditions,
and General Procedures
Hygromycin A and 2L-2-amino-2-deoxy-4,5-O-methylene-neo-inositol (sub-
unit C) were kindly supplied by Pfizer Inc. [2-3H] myo-inositol (20.0 Ci/mmol)
was purchased from Moravek Biochemicals. [carboxyl-14C]-4-hydroxyben-
zoic acid was obtained from American Radiolabeled Chemicals Inc. All other
antibiotics and chemicals were purchased from Sigma Aldrich. The E. coli
DtolC strain, deficient in the outer membrane protein TolC, was procured
from the E. coli Genetic Stock Center at Yale University. All E. coli strains
were grown following standard protocols (Sambrook and Russell, 2001).
S. hygroscopicus wild-type and mutant strains were maintained using media9 Elsevier Ltd All rights reserved
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Gene Putative Function Primer Name Primer Sequence (50-30)
hyg6 Methyltransferase hyg6_Forw CGCCCCTCGACCGCGAAGACCTTCTGGGGGCAGCGGATGATTCCGGGGATCCGTCGACC
hyg6_Rev ATGGTGGTCCGGCCTCCTCGTGTCGTCTGCGTGCCACTGTGTAGGCTGGAGCTGCTTC
hyg7 D-aminoacylase hyg7_Forw GACGACACGAGGAGGCCGGACCACCATGCATGACCTGATATTCCGGGGATCCGTCGACC
hyg7_Rev TCGCGCGCCCCGCCGGTGCGGCGGGCCGCCTCGCGGTCATGTAGGCTGGAGCTGCTTC
hyg8 Aminotransferase hyg8_Forw CTGTCCGAGAAGGACTACGTCATCGAGCGGGACCGGCTGATTCCGGGGATCCGTCGACC
hyg8_Rev GGTTTCCGCGAAGAACGCGTCCTGCATCGCCCGTGACCGTGTAGGCTGGAGCTGCTTC
hyg17 myo-inositol
dehydrogenase
hyg17_Forw TTCCGCCGTCGTGCGGGCCGCGGGGGTGAGCCGGTGAGCATTCCGGGGATCCGTCGACC
hyg17_Rev GTCATCCCCTCGCGCCGCCGGCCAGGACGCCACCGGTCATGTAGGCTGGAGCTGCTTC
hyg18 myo-inositol-1-
phosphate synthase
hyg18_Forw GGCCTGCGGCCCGGAGATTTCGCGAAGGGAAGAACCATGATTCCGGGGATCCGTCGACC
hyg18_Rev CACGGGTCGGATCTCGGTTCGGAAACGCCCGGCGGCTCATGTAGGCTGGAGCTGCTTC
hyg25 myo-inositol-1-
phosphatase
hyg25_Forw CACGCATGTCCGATACGACCGAATCGGGGTTGAGTGATGATTCCGGGGATCCGTCGACC
hyg25_Rev GCGTCAGCGAATTCTGAGCCGCGCAACCGTCCGCGGTCATGTAGGCTGGAGCTGCTTC
hyg29 Methyltransferase hyg29_Forw GCCGCCCGACCCGAGGCGCCCGGAGACGCCGCCGCGATGATTCCGGGGATCCGTCGACC
hyg29_Rev GCCGTCCGGCCTCTGTCCACCAGCTGTGCGCCGCCTCCATGTAGGCTGGAGCTGCTTC
The 39-nucleotide homologous region flanking the targeted gene is indicated in normal font. The italicized primer region is homologous to pIJ773.and culture conditions as described earlier (Habib et al., 2003; Palaniappan
et al., 2006). For qualitative analysis of the fermentation broths, the mycelium
was removed by centrifugation and the supernatant was examined by HPLC
and LC-MS as described previously (Palaniappan et al., 2006).
Targeted Disruption of the Aminocyclitol Biosynthetic Genes
The individual hyg genes were individually replaced with apramycin resistance
cassette using the PCR-targeted Streptomyces gene replacement method
(Gust et al., 2003; Palaniappan et al., 2006). The primer sequences used to
amplify the resistance cassette from pIJ773 plasmid are listed in Table 3. All
of the genes, except hyg29, were first disrupted in cosmid 17E3. For hyg29
disruption, cosmid 15A10 was used. The recombinant cosmids were subse-
quently transferred to S. hygroscopicus wild-type by conjugation and the
exoconjugants resulting from homologous recombination were selected
based on resistance to apramycin. The genotype of the mutant strains was
confirmed by PCR amplification using an appropriate set of outer primers
(Table 3), and by sequencing the PCR product.
In the studies on hyg8, the apramycin resistance gene was removed from the
hyg8 mutant cosmid 17E3 using FLP recombinase. This cosmid with the 81 bp
scar in place of hyg8 sequence was then used to for replacement of hyg7
with the apramycin resistance gene. The resulting 17E3 cosmid derivative
was introduced into the wild-type S. hygroscopicus to provide the desired
hyg7+hyg8 deletion mutant.
Chemical Complementation Studies
The wild-type and appropriate mutant strains were grown in 5 ml production
medium and treated with an amino sugar (the HA C subunit, glucosamine,
galactosamine, or valienamine,) after 24 hr of fermentation to a final concentra-
tion of 5 mM. [2-3H] myo-inositol and [carboxyl-14C] 4-hydroxybenzoic acid
were added to a final concentration of 0.4 mCi/ml. The supernatant was
analyzed by HPLC and LC-MS after 6 days of fermentation (Palaniappan
et al., 2006). Fermentation broths from the radiolabeled precursor feeding
studies were analyzed by Beckman HPLC system linked to Beta-Ram (R)
radioactivity quantization system (IN/US Systems, Inc.).
Quantitative Analysis of Antibiotic Production
Quantitative analyses of production of HA and its analogs were determined
from triplicate cultures of the wild-type and mutant strains. Pure HA was
used to generate a standard curve of peak area versus amount in mg within
a 5 to 50 mg range. Then 50 ml filtered fermentation broth from each culture
was used for HPLC analyses. The amounts of HA and related products in
each injection sample were determined from their individual peak areas using
the standard curve as reference and used to determine total production in the
fermentations.Chemistry & Biology 16, 1180–11Purification and Characterization of Desmethylenehygromycin A (5)
and 500-Dihydrodesmethylenehygromycin A (6)
The desmethylene HA analogs (5, 6) (Figure 1) produced by the Dhyg6 strain
were extracted from culture filtrate and purified as described earlier (Palaniap-
pan et al., 2006; Habib et al., 2003). The two products were characterized by
MS and NMR techniques. 1H-NMR spectra were recorded on a Bruker AMX-
400 NMR. Two-dimensional correlated spectography correlation spectra were
recorded on a Bruker AMX-600 NMR spectrometer. Coupling constants (J)
were expressed in Hertz. Abbreviations for multiplicities are: s = singlet, d =
doublet, t = triplet, q = quartet, m = multiplet.
Hygromycin A (1)
1H-NMR (400 MHz, D2O) d 7.10 (1H, d, J = 8.0, H-9
0), 7.01 (1H, s, H-30), 6.88 –
6.91 (2H, m, H-50, H-80), 5.69 (1H, d, J = 4.4, H-100), 5.18, 4.83 (2H, -OCH2O-),
4.50 – 4.48 (1H, m, H-2), 4.40 – 4.18 (5H, m, H-200, H-400, H-4, H-5, H-6), 4.08
(1H, t, J = 2.8, H-300), 3.95 (1H, dd, J = 5.2, H-1), 3.82 (1H, dd, J = 3.6, H-3),
2.16 (3H, s, H-600), 2.02 (3H, s, a-CH3).
Desmethylenehygromycin A (5)
1H-NMR (400 MHz, D2O) d 7.14 (1H, d, J = 8.4, H-9
0), 6.99 (1H, s, H-30), 6.94
(1H, s, H-50), 6.93 (1H, d, J = 8.4, H-80), 5.72 (1H, d, J = 4.4, H-100), 4.74 –
4.62 (1H, m, H-2), 4.41 – 4.40 (2H, m, H-300, H-400), 4.30 – 4.22 (1H, m, H-200),
4.02 (1H, t, J = 2.8, H-5), 3.95 – 3.92 (2H, m, H-1, H-3), 3.72 (2H, dd,
J = 10.0, 2.8, H-4, H-6), 1.99 (6H, s, a-CH3, H-6
00).
500-Dihydrodesmethylenehygromycin A (6)
1H-NMR (D2O, 400 MHz) d 7.17 (1H,d, J = 8.2, H-9
0), 7.08 (1H, s, H-30), 7.01
(1H, s, H-50), 6.99 (1H, d, J = 8.2, H-80), 5.69 (1H, d, J = 4.4, H-100), 4.7 (1H,
partially obscured by solvent peak, H-2), 4.33-4.29 (2H, m, H-200, H-300), 4.11
(1H, t, J = 2.8, H-5), 4.03 (2H, dd, J = 10.0, 4.2, H-1, H-3), 3.87-3.80 (3H, m,
H-4, H-6, H-500), 3.74 (1H, t, J = 6.0, H-400) 2.08 (3H, s, a-CH3), 1.13 (3H, d,
J = 6.8, H-600).
MIC90 of HA and Analogs for DtolC E. coli
Five microliters of an overnight culture of DtolC E. coli were added to 195 ml
final volume of fresh LB supplemented with HA or its analogs (Figure 1). The
tubes were grown with shaking for 2 hr at 37C and the absorbance at
600 nm was measured. The MIC90 was defined as the lowest concentration
of the antibiotic at which 90% of growth was inhibited compared to a control
E. coli culture grown in the absence of any antibiotic.
Coupled Transcription-Translation Assay
All coupled transcription-translation experiments were performed using an
E. coli lysate-based system in the presence and absence of antibiotics as
described previously (Dinos et al., 2004; Szaflarski et al., 2008). Reactions
were transferred into 96-well microtiter plates and the GFP fluorescence
was measured with a Typhoon Scanner 9400 (Amersham Bioscience) using89, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1187
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Biosynthesis of Aminocyclitol Subunit Hygromycin Aa Typhoon blue laser module (Amersham Bioscience). Images were then quan-
tified using ImageQuantTL (GE Healthcare) and represented graphically using
SigmaPlot (Systat Software, Inc.).
Hygromycin Sensitivity of Dhyg29 strain
The MIC95 of HA for the Dhyg29 mutant and the wild-type strain were deter-
mined by the agar plate dilution method (Dhote et al., 2008). Briefly, spores
were plated on ISP2 agar plates containing varying amounts of HA, incubated
at 30C for 48 hr, and scored for growth. The MIC95 was defined as the lowest
concentration of HA that prevented visible growth of 95% or more of the
colony forming units on the agar plate.
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